← Back to Search

Behavioural Intervention

Provider Training Methods for Fetal Alcohol Spectrum Disorders

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two methods of training mental health providers in the US to screen for FASD & use a caregiver app to better support families.

Who is the study for?
This trial is for mental health providers in the U.S. who work with children aged 3 to 12 or their families, are fluent in English, and have internet access. It's not for those working outside the U.S. or who don't serve this age group.
What is being tested?
The study tests 'FMF Connect Pro,' a tool helping providers screen for prenatal alcohol exposure and diagnose FASD. Providers will compare two training methods: a tele-mentoring ECHO approach and self-directed learning, against a waitlist control.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience varying levels of comfort with technology or changes in workload.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adoption: Change in FASD-Informed Care Self-Efficacy
Adoption: Change in Provider FASD-Informed Care Knowledge
Adoption: Number of ECHO Sessions Completed
+10 more
Secondary study objectives
Contextual determinants on outcomes: Mean score on the Theoretical Domains Framework (TDF) survey

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: FMF (Families Moving Forward) Connect Pro with Self-directed materialsExperimental Treatment2 Interventions
Mental health providers are trained in FMF Connect Pro with self-directed materials. FMF Connect Pro teaches mental health providers how to do routine screening of prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support caregivers in using the FMF Connect app. The FMF Connect Pro Dashboard organizes intervention content for providers and includes tools for client progress monitoring. In this arm, mental health providers will access similar didactic content as ECHO participants, but in an asynchronous format on the FMF Connect Pro Dashboard. This will include pre-recorded videos, activities, and additional resources for further learning.
Group II: FMF (Families Moving Forward) Connect Pro with ECHO implementationExperimental Treatment2 Interventions
Mental health providers are trained in FMF Connect Pro with ECHO (Extension of Community Healthcare Outcomes) tele-mentoring. FMF Connect Pro teaches mental health providers how to do routine screening of prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support caregivers in using the FMF Connect app. The FMF Connect Pro Dashboard organizes intervention content for providers and includes tools for client progress monitoring. In this arm, providers receive training in FMF Connect Pro through 13 bi-weekly ECHO tele-mentoring sessions. Each ECHO session involves brief didactic presentations by Hub Team members on FASD-informed care principles and FMF Connect content and case-based discussions and recommendations by Spoke Sites.
Group III: Waitlist Comparison GroupActive Control1 Intervention
The waitlist comparison group will receive FMF Connect Pro via Self-directed materials after completing assessments at the 6-month timepoint.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
872 Previous Clinical Trials
549,841 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,398 Total Patients Enrolled

Media Library

ECHO implementation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05960461 — N/A
Fetal Alcohol Syndrome Research Study Groups: Waitlist Comparison Group, FMF (Families Moving Forward) Connect Pro with ECHO implementation, FMF (Families Moving Forward) Connect Pro with Self-directed materials
Fetal Alcohol Syndrome Clinical Trial 2023: ECHO implementation Highlights & Side Effects. Trial Name: NCT05960461 — N/A
ECHO implementation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05960461 — N/A
~167 spots leftby Apr 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top